These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2617478)

  • 41. The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin.
    Hallam TJ; Scrutton MC; Wallis RB
    FEBS Lett; 1983 Oct; 162(1):142-6. PubMed ID: 6617886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
    Best LC; Holland TK; Jones PB; Russell RG
    Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
    Vargaftig BB; Fouque F; Benveniste J; Odiot J
    Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin-stimulated phosphoinositide hydrolysis in platelets from post-withdrawal alcoholics.
    Simonsson P; Berglund M; Oreland L; Moberg AL; Alling C
    Alcohol Alcohol; 1992 Nov; 27(6):607-12. PubMed ID: 1337965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF.
    Sweatt JD; Schwartzberg MS; Frazer M; Cragoe EJ; Blair IA; Reed PW; Limbird LE
    Circ Res; 1987 Nov; 61(5 Pt 2):II6-11. PubMed ID: 2822286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets.
    Cox CP
    Thromb Res; 1986 Jan; 41(2):211-22. PubMed ID: 2421432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
    Cox CP; Wood KL
    Thromb Res; 1987 Aug; 47(3):249-57. PubMed ID: 3629553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine.
    Ostermann G; Brachwitz H; Till U
    Biomed Biochim Acta; 1984; 43(3):349-55. PubMed ID: 6743307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet function defects in chronic alcoholism.
    Mikhailidis DP; Jenkins WJ; Barradas MA; Jeremy JY; Dandona P
    Br Med J (Clin Res Ed); 1986 Sep; 293(6549):715-8. PubMed ID: 3094624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet serotonin concentration and clinical status in alcohol withdrawal syndrome, preliminary results.
    Llinás SG; Caballero AJ; Peñalver JC; Valdés R
    MEDICC Rev; 2014 Jan; 16(1):37-42. PubMed ID: 24487674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coëffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
    Fourcade O; Simon MF; Litt L; Samii K; Chap H
    Anesth Analg; 2004 Aug; 99(2):393-8, table of contents. PubMed ID: 15271713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor.
    Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ
    Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH; Johnson B
    J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.